Jazz Pharmaceuticals PLC (JAZZ): Today's Featured Health Care Laggard

Jazz Pharmaceuticals ( JAZZ) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.7%. By the end of trading, Jazz Pharmaceuticals fell $1.04 (-1.4%) to $72.75 on average volume. Throughout the day, 1,154,966 shares of Jazz Pharmaceuticals exchanged hands as compared to its average daily volume of 988,600 shares. The stock ranged in price between $70.33-$74.10 after having opened the day at $73.96 as compared to the previous trading day's close of $73.79. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 34.6%, Utah Medical Products ( UTMD), down 13.0%, Synthetic Biologics ( SYN), down 12.3% and Neostem ( NBS), down 7.8%.

Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other countries. Jazz Pharmaceuticals has a market cap of $4.3 billion and is part of the drugs industry. Shares are up 36.7% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Jazz Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front, Rockwell Medical ( RMTI), up 19.5%, Prothena Corporation ( PRTA), up 15.9%, XOMA ( XOMA), up 15.3% and Alnylam Pharmaceuticals ( ALNY), up 15.0% , were all gainers within the health care sector with Becton Dickinson ( BDX) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again